Abstract
In Italy, about 15,000 patients are known to suffer from myasthenia gravis; however, in other cases the condition is not diagnosed or is confused with other pathologies. In Europe, it is thought that about 6 in 100,000 inhabitants are affected, and in the USA the incidence has been estimated at 20 cases for every 100,000 inhabitants. As regards the patient’s age at onset, there are two peaks: between 20 and 40 years of age (women most affected) and 60 to 80 years (no difference between the sexes). This data would suggest that myasthenia gravis patients rarely undergo surgery; on the contrary, as thymectomy causes a significant improvement in symptoms in 40–90% of cases and complete remission of the disease in 25% of cases, surgery in patients with myasthenia gravis (especially in large centers with a Chest Surgery Unit) is not uncommon [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kaplan JA, Slinger PD (2003) Thoracic anesthesia, 3rd edn. Elsevier Science, pp 281–294
Osserman KE, Genkins G (1971) Studies in myasthenia gravis: Review of a twenty-year experience in over 1,200 patients. J Mt Sinai Hosp 38:497–503
Hermann C, Lindstrom JM, Kessey JC et al (1985) Myasthenia gravis-Current concepts. West J Med 142:797
Romi F, Gilhus NE, Aarli JA (2005) Myasthenia gravis: Clinical, immunological, and therapeutic advance. Acta Neurol Scand 111:134–141
Millard CB, Bromfield CA (1995) Anticholinesterases: Medical applications of neurochemical principles. J Neurochem 64:1909–1918
Gaidos P, Chevret S, Toyka K (2002) Plasma exchange for myasthenia gravis. Cochrane Database Syst Rev 4:CD002275
Gaidos P, Chevret S, Toyka K (2003) Intravenous immunoglobulin for myasthenia gravis. Cochrane Database Syst Rev 2:CD002277
Philip E, Levarenne J, Dordain G (1985) Myasthénie et médicaments: Évaluation critique des contre-indications. Press Med 14, 515–516
Martin C, Auffray JP (1990) Il periodo perioperatorio del miastenico. Anestesia Rianimazione, 36657 C10. EMC, Roma, p 8
Viby-Mogensen J (1985) Interaction of other drugs with muscle relaxants. In: Katz RJ (ed) Muscle relaxants. Basic and critical aspects. Gune and Stratton, Orlando, pp 233–256
Swash M, Ingram DA (1992) Adverse effect of verapamil in myasthenia gravis. Muscle Nerve 15(3):396–398
Scappaticci KA, Ham JA, Sohn J et al (1982) Effects of furosemide on the neuromuscolar junction. Anesthesiology 57:381–388
Rall TW, Schleifer LS (1985) Drugs effective in the therapy of the epilepsies. In: Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics. MacMillan Publishing Co., New York, pp 446–472
Booker HE, Chun RW, Sanguini M (1970) Myasthenia gravis syndrome associated with trimethadione. JAMA 212(13):2262–2263
Orts A, Marti JL, Baltar I et al (1979) Inhibition neuro-musculaire de nouveaux antibiotiques aminoglucosids. Ann Anesthesiol Fr 20:25–30
Gunduz A, Turedi S, Kalkan A et al (2006) Levofloxacin induced myasthenia crisis. Emerg Med J 23:662
Sieb JP (1998) Fluoroquinolone antibiotics block neuromuscolar transmission. Neurology 50:804–807
Abel M, Eisenkraft JB (2002) Anesthetic implications in myasthenia gravis. Mt Sinai J Med 69:31–37
Eisenkraft JB, Book VJ, Mann SM et al (1988) Resistance to succinylcholine in myasthenia gravis: A doseresponse study. Anesthesiology 69:760–763
Baraka A (1992) Suxamethonium block in the myasthenic patient. Correlation with plasma cholinesterase. Anesthesia 47:217–219
Seigne RD, Scott RP (1994) Mivacurium chloride and myasthenia gravis. Br J Anaesth 72:468–469
Blitt CD, Wright WA, Peat J (1975) Pancuronium and the patient with myasthenia gravis. Anesthesiology 42:624–626
Itoh H, Shibata K, Nitta S (2001) Difference in sensitivity to vecuronium between patients with ocular and generalized myasthenia gravis. Br J Anaesth 87(6):885–889
Itoh H, Shibata K, Nitta S (2002) Sensitivity to vecuronium in seropositive and seronegative patients with myasthenia gravis. Anesth Analg 95(1):109–113
Mann R, Blobner M, Jelen-Esselbom S et al (2000) Preanesthetic train-of-four fade predicts the atracurium requirement of myasthenia gravis patients. Anesthesiology 93(2):346–350
Smith CE, Donati F, Bevin DR (1989) Cumulative dose-response curves for atracurium in patients with myasthenia gravis. Can J Anaesth 36:402–406
Baraka AS, Siddik S, Kawkabani NI (1999) Cisatracurium in a myasthenic patient undergoing thymectomy. Can J Anesth 46(8):779–782
Baraka AS, Taha SK, Kawkabani NI (2000) Neuromuscular interaction of sevoflurane-cisatracurium in a myasthenic patient. Can J Anesth 47(6):562–565
Seigne RD, Scott RP (1994) Mivacurium chloride and myasthenia gravis. Br J Anaesth 72:468–469
Cordero Escobar I, Benitez Tang SM, Parisi Lopez N (2002) Use of mivacurium chloride during transsternal thymectomy in myasthenic patient. Rev Esp Anestesiol Reanim 49(7):360–364
Gissen AJ, Karris JH, Nastuk VL (1966) Effect of halothane on neuromuscular transmission. JAMA 197:770–774
Nilsson E, Muller K (1990) Neuromuscolar effects of isoflurane in patients with myasthenia gravis. Acta Anaesth Scand 34:126–131
Kadosaki M, Enzan K, Horiguchi T et al (1993) Severity of myasthenia gravis is related to the degree of neuromuscular blocking effect by isoflurane. Masui 42:906–909
Eisenkraft JB, Papatestas AE, Sivak M (1984) Neuromuscolar effects of halogenated agents in patients with myasthenia gravis (abstract). Anesthesiology 61:A307
Russel SH, Hood JR, Campkin M (1993) Neuromuscolar effects of enflurane in myasthenia gravis (abstract) Br J Anaesth 71:766P
Nitahara K, Sugi Y, Higa K et al (2007) Neuromuscolar effects of sevoflurane in myasthenia gravis patients. Br J Anaesth 98(3):337–341
Kiran U, Choudhury M, Saxena L et al (2000) Sevoflurane as a sole anaesthetic agent for thymectomy in myasthenia gravis. Acta Anaesth Scand 44:351–353
Baraka A, Siddik S, el Rassi T et al (2000) Sevoflurane anesthesia in a myasthenic patient undergoing transternal thymectomy. Middle East J Anesthesiol 15(6):603–609
Caldwell JE, Laster MJ, Magorian T et al (1991) The neuromuscolar effects of desflurane alone and combined with pancuronium or succinylcholine in humans. Anesthesiology 74:412–418
Hubler M, Litz RJ, Albrecht DM (2000) Combination of balanced and regional anaesthesia for minimally invasive surgery in a patient with myasthenia gravis. Eur J Anaesthesiol 17(5):325–328
Ng JM (2006) Total intravenous anesthesia with propofol and remifentanil for video-assisted thoracoscopic thymectomy in patients with myasthenia gravis. Anesth Analg 103(1):256–257
Fodale V, Praticò C, Piana F et al (2003) Propofol and remifentanil without muscle relaxants in a patient with myasthenia gravis for emergency surgery. Can J Anaesth 50(10):1083–1084
Della Rocca G, Coccia C, Diana L et al (2003) Propofol or sevoflurane anesthesia without muscle relaxant allow the early extubation of myasthenic patient. Can J Anaesth 50(6):547–552
De Grood PM, Mitusukuri S, Van Egmond J et al (1987) Comparison of etomidate and propofol for anaesthesia in microlaryngeal surgery. Anaesthesia 42:366–372
Bagshaw O (2007) A combination of total intravenous anesthesia and thoracic epidural for thymectomy in juvenile myasthenia gravis. Paediatr Anaesth 17(4):370–374
El-Dawlatly AA, Al Kattan K, Hajjar W et al (2005) Anesthetic implications for video assisted thoracoscopic thymectomy in myasthenia gravis. Middle East J Anesthesiol 18(2):339–345
Matsuo S, Rao DBS, Chaudry I et al (1978) Interaction of muscle relaxants and local anesthetics at the neuromuscolar junction. Anesth and Analg 57:580–587
Lopez-Berlanga JL, Garutti I, Martinez-Campos E et al (2006) Bilateral paravertebral block anesthesia for thymectomy by video-assisted thoracoscopy in patients with myasthenia gravis. Rev Esp Anestesiol Reanim 53(9):571–574
Mulder DG, Hermann C, Buckberg GB (1974) Effect of thymectomy in patients with myasthenia gravis. Am J Surg 128:202–206
Cohn HE, Solit RW, Schatz NS et al (1974) Surgical treatment in myasthenia gravis: A 27-year experience. J Thorac Cardiovasc Surg 68:876–885
Papatestas AE, Alpert LL, Ossermann KE et al (1971) Studies in myasthenia gravis: Effects of thymectomy, results on 185 patients with nonthymomatous and thymomatous myasthenia gravis 1941-1969. Am J Med 50:465–474
Loach AB, Young AC, Spalding JMK et al (1975) Postoperative management after thymectomy. Br Med J 1:309–312
Leventhal SR, Orkin FK, Hirsh RA (1980) Prediction of the need for post-operative mechanical ventilation in myasthenia gravis. Anesthesiology 53:26–30
Gracey DR, Divertie MB, Howard FM et al (1984) Postoperative respiratory care after transsternal thymectomyin myasthenia gravis. A three-years experience in 53 patients. Chest 86:67–71
Younger DS, Braun NMT, Jaretzki A et al (1984) Myasthenia gravis: Determinants for independent ventilation after transsternal thymectomy. Neurology 34:336–340
Pavlin EG, Holle RH, Schoene RB (1989) Recovery of airway protection compared with ventilation in humans after paralysis with curare. Anesthesiology 70:381–385
Oosterhuis HJ (1981) Observations of the natural history of myasthenia gravis and the effect of thymectomy. Ann NY Acad Sci 377:678–690
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Italia
About this chapter
Cite this chapter
Indrizzi, V.L., Gazzotti, F., Fanigliulo, M.A., Tassi, A. (2008). Anesthesiological Problems in Thymus Gland Surgery. In: Lavini, C., Moran, C.A., Morandi, U., Schoenhuber, R. (eds) Thymus Gland Pathology. Springer, Milano. https://doi.org/10.1007/978-88-470-0828-1_13
Download citation
DOI: https://doi.org/10.1007/978-88-470-0828-1_13
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0827-4
Online ISBN: 978-88-470-0828-1
eBook Packages: MedicineMedicine (R0)